The specific formulation for the aesthetic medicine indication of Dysport is under European Union regulatory approval.
2
Botulinum toxins (Botox, Dysport etc) still rank as the number one non-surgical procedure followed by hyaluronic acid filler treatments.
3
Early in the treatment programme, three patients who received a dose of 1000 units Dysport showed systemic side-effects and generalized muscle weakness.
4
Dysport was initially developed as a treatment of movement disorders or muscle spasticity, and has now been approved for aesthetic indications in 20 countries.
5
A unit at the world's biggest food group that makes Botox rival Dysport may fetch at least 6 billion Swiss francs ($6 billion).